France's leading company
in clinical quality management

Join us

Sunnikan is looking for Clinical Research Quality Management Consultants

In 2021, Sunnikan worked on

  • 190

  • 120

  • in 30
    different countries

  • 70
    training sessions

  • 50
    regulatory support projects

Our training programmes

Read the programme

As a training body, Sunnikan offers regulatory and quality training sessions

Our regulatory monitoring

Read our monthly newsletter

Sunnikan offers monitoring and support tools to help companies keep up to speed on their regulatory obligations

Case studies

A pharmacovigilance audit on an international scale

In order to ensure compliance with the regulations in force, the French parent company of an international pharmaceutical laboratory asked Sunnikan to carry out the audit for its distributors’ pharmacovigilance activities around the world.


Operations Director

A series of audits spanning three continents

A sponsor for a pivot trial spanning three different continents asked Sunnikan for help with ensuring the trial met quality standards.
Sunnikan drew up a schedule of ad hoc audits for the primary stakeholders (sponsor, coordinating CRO, investigation sites, medical imagining centralisation, data management, statistics, etc.) and carried out the audits in question throughout the trial’s life-span.
As medical imaging was the primary evaluation criterion, this aspect was taken into particular consideration, with French, European and American frameworks also taken into account.


Operations Director

Ten audits in a month for the same clinical trial

As part of its plans to demonstrate progress made in a pivot trial to a potential American partner, the trial sponsor asked Sunnikan for help with carrying out ten audits of the trial’s primary stakeholders.
Drawing on a team comprised of a dozen consultants, and its standardised auditing methods and report writing system, Sunnikan carried out all ten audits in just a month, providing a general overview and detailed snapshot of the trial’s progress so far.

Catherine MÉRAT

Operations Director